Literature DB >> 30017828

Nivolumab-Induced Hemophilia A Presenting as Gastric Ulcer Bleeding in a Patient With NSCLC.

Ryoji Kato1, Hidetoshi Hayashi2, Keigo Sano3, Kohei Handa4, Takahiro Kumode3, Hiroto Ueda1, Tatsuya Okuno1, Hisato Kawakami1, Itaru Matsumura3, Masatoshi Kudo4, Kazuhiko Nakagawa1.   

Abstract

Entities:  

Keywords:  Acquired hemophilia; Immune-related adverse event; NSCLC; Nivolumab

Mesh：

Substances：

Year:  2018        PMID： 30017828     DOI： 10.1016/j.jtho.2018.06.024

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  2 in total

1.  A Case of Acquired Factor V Inhibitor Following Nivolumab Administration.

Authors:  Wataru Kida; Muneo Nakaya; Akiko Ito; Yasuji Kozai; Masato Bingo
Journal:  Cureus       Date:  2022-01-27

2.  Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review.

Authors:  Nabil E Omar; Kareem A El-Fass; Abdelrahman I Abushouk; Noha Elbaghdady; Abd Elmonem M Barakat; Ahmed E Noreldin; Dina Johar; Mohamed Yassin; Anas Hamad; Shereen Elazzazy; Said Dermime
Journal:  Front Immunol       Date:  2020-10-21       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.